Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Why DexCom, Inc. (DXCM) Went Up On Friday

In This Article:

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other Friday's top performers.

The stock market ended the trading week on a strong note, with all major indices clocking in strong gains, as investors cheered better-than-expected non-farm payrolls last month while digesting more corporate earnings results.

The tech-heavy Nasdaq led the rally among all major indices, finishing up by 1.51 percent. The S&P 500 clocked in a 1.47-percent gain, while the Dow Jones grew by 1.39 percent.

Ten companies also mimicked the broader market optimism following impressive earnings performance and an optimistic outlook for the rest of the year. In this article, we have identified the 10 top performers on Friday and detailed the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.

Why DexCom, Inc. (DXCM) Went Up On Friday?
Why DexCom, Inc. (DXCM) Went Up On Friday?

A doctor demonstrating how to use the medical device to a patient with diabetes.

DexCom, Inc. (NASDAQ:DXCM)

Dexcom Inc. surged by 16.17 percent on Friday to end at $81.62 apiece after reporting an impressive 12.49 percent revenue growth in the first quarter of the year and maintaining outlook guidance for the rest of 2025.

In a statement, DexCom, Inc. (NASDAQ:DXCM) said that revenues improved to $1.036 billion in the past three months from the $921 million registered in the same period last year.

Net income, however, declined by 28 percent to $105.4 million from $146.4 million in the same comparable period.

“As we progress through 2025, we will advance our product portfolio with the launch of our Dexcom G7 15-Day system and continue to advocate for expanded global access to our glucose biosensors,” said DexCom, Inc. (NASDAQ:DXCM) CEO Kevin Sayer.

Looking ahead, the company expects full-year revenues to increase by 14 percent to $4.6 billion, and adjusted EBITDA margin to expand by 30 percent year-on-year.

Overall, DXCM ranks 6th on our list of Friday's top performers. While we acknowledge the potential of DXCM as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DXCM but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.